2018 annual financial data
Corcept Therapeutics Incorporated 2018 Operating margin
Corcept Therapeutics Incorporated 2018 operating margin with verified reported…
Direct answer
Operating margin was 35.62%.
Operating income was 89,496,000 USD and net income was 75,410,000 USD.
Operating cash flow was 115,665,000 USD.
Get free Corcept Therapeutics Incorporated email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 251,247,000 USD
- Operating income
- 89,496,000 USD
- Net income
- 75,410,000 USD
- Operating cash flow
- 115,665,000 USD
Explore related company data
View all 2018 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Net marginView Operating cash flow marginView all Corcept Therapeutics Incorporated financial years